118 related articles for article (PubMed ID: 24628584)
1. Topical photodynamic therapy using different porphyrin precursors leads to differences in vascular photosensitization and vascular damage in normal mouse skin.
Middelburg TA; de Vijlder HC; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
Photochem Photobiol; 2014; 90(4):896-902. PubMed ID: 24628584
[TBL] [Abstract][Full Text] [Related]
2. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
3. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
4. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.
Middelburg TA; de Bruijn HS; Tettero L; van der Ploeg van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
J Photochem Photobiol B; 2013 Sep; 126():26-32. PubMed ID: 23892187
[TBL] [Abstract][Full Text] [Related]
5. Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation.
Togsverd-Bo K; Lerche CM; Philipsen PA; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2012 Apr; 21(4):260-4. PubMed ID: 22320713
[TBL] [Abstract][Full Text] [Related]
6. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
7. Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.
de Bruijn HS; Brooks S; van der Ploeg-van den Heuvel A; Ten Hagen TL; de Haas ER; Robinson DJ
PLoS One; 2016; 11(2):e0148850. PubMed ID: 26872051
[TBL] [Abstract][Full Text] [Related]
8. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
Lesar A; Ferguson J; Moseley H
Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
[TBL] [Abstract][Full Text] [Related]
9. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
10. PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination.
Thissen MR; de Blois MW; Robinson DJ; de Bruijn HS; Dutrieux RP; Star WM; Neumann HA
J Invest Dermatol; 2002 Feb; 118(2):239-45. PubMed ID: 11841539
[TBL] [Abstract][Full Text] [Related]
11. Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
Nissen CV; Philipsen PA; Wulf HC
Br J Dermatol; 2015 Sep; 173(3):760-6. PubMed ID: 25997508
[TBL] [Abstract][Full Text] [Related]
12. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources.
Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M
Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358
[TBL] [Abstract][Full Text] [Related]
13. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
Juzeniene A; Juzenas P; Ma LW; Iani V; Moan J
Br J Dermatol; 2006 Oct; 155(4):791-9. PubMed ID: 16965430
[TBL] [Abstract][Full Text] [Related]
14. Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors.
Juzenas P; Juzeniene A
Photodiagnosis Photodyn Ther; 2010 Sep; 7(3):152-7. PubMed ID: 20728838
[TBL] [Abstract][Full Text] [Related]
15. MAL-associated methyl nicotinate for topical PDT improvement.
Stringasci MD; Ciol H; Romano RA; Buzza HH; Leite IS; Inada NM; Bagnato VS
J Photochem Photobiol B; 2020 Dec; 213():112071. PubMed ID: 33242779
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models.
Fujita AK; Rodrigues PG; Requena MB; Escobar A; da Rocha RW; Nardi AB; Kurachi C; de Menezes PF; Bagnato VS
Photodiagnosis Photodyn Ther; 2016 Sep; 15():236-44. PubMed ID: 27288253
[TBL] [Abstract][Full Text] [Related]
18. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin.
Henderson BW; Vaughan L; Bellnier DA; van Leengoed H; Johnson PG; Oseroff AR
Photochem Photobiol; 1995 Oct; 62(4):780-9. PubMed ID: 7480155
[TBL] [Abstract][Full Text] [Related]
19. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
[TBL] [Abstract][Full Text] [Related]
20. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]